lysakare
advanced accelerator applications - l-arginine hydrochloride, l-lysine hydrochloride - säteilyvammat - detoxifying agents for antineoplastic treatment - lysakare on tarkoitettu vähentämään munuaisten säteilyaltistuksen aikana peptidi-reseptorin lääkesädehoidot (prrt) kanssa lutetium (177lu) oxodotreotide aikuisilla.
dienogest besins 2 mg tabletti
laboratoires besins international - dienogest - tabletti - 2 mg - dienogesti
elzonris
stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastiset aineet - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).
vydura
pfizer europe ma eeig - rimegepant - migreenihäiriöt - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
scemblix
novartis europharm limited - asciminib hydrochloride - leukemia, myelogeeninen, krooninen, bcr-abl positiivinen - antineoplastiset aineet - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.
trientine waymade 200 mg kapseli, kova
waymade b.v. - trientine dihydrochloride - kapseli, kova - 200 mg - trientiini
cydectin pour-on vet 5 mg/ml kertavaleluliuos
zoetis animal health aps - moxidectine - kertavaleluliuos - 5 mg/ml - moksidektiini
equest vet 18.92 mg/g oraaligeeli
zoetis animal health aps - moxidectine - oraaligeeli - 18.92 mg/g - moksidektiini
equest pramox 19,5 mg/g + 121,7 mg/g oraaligeeli
zoetis animal health aps - moxidectine, praziquantel - oraaligeeli - 19,5 mg/g + 121,7 mg/g - moksidektiini
evusheld
astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.